Related Experiment Video
Updated: Jan 31, 2026

Multifocal Electroretinograms
Published on: December 4, 2011
Remarkable improvement in progressive multifocal leukoencephalopathy following acute pyelonephritis with bacteremia
Eiichiro Amano1, Kokoro Ozaki1, Satoru Ishibashi1
1Department of Neurology and Neurological Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8519, Japan.
Insights
Progressive multifocal leukoencephalopathy (PML) is a rare brain infection. This case report details a patient without HIV who improved after an E. coli infection, suggesting a potential link.
Area of Science:
- Neurovirology
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by the John Cunningham (JC) virus.
- PML primarily affects individuals with compromised immune systems, including those with HIV/AIDS, hematological malignancies, autoimmune disorders, and those on immunosuppressive therapy.
Observation:
- The study presents a unique case of PML in a patient without HIV infection.
- This patient experienced acute pyelonephritis with Escherichia coli bacteremia.
Findings:
- The patient demonstrated significant neurological improvement following the E. coli infection and subsequent treatment.
- This observation suggests a potential, previously undocumented, interaction between bacterial infections and JC virus reactivation or pathogenesis.
Implications:
- This case challenges the traditional understanding of PML's typical patient profile and triggers.
- Further research into the immunological mechanisms underlying this patient's recovery could reveal novel therapeutic strategies for PML.
- Investigating the interplay between bacterial infections and viral reactivation in immunocompromised individuals is warranted.
Abstract:
Progressive multifocal leukoencephalopathy (PML) is caused by John Cunningham (JC) virus in immunocompromized patients such as those with human immunodeficiency virus (HIV) infection, hematological malignancy, autoimmune disorder, and immunodeficiency disorder as well as those undergoing chemotherapy or immunosuppressive therapy. No effective treatments have been established for PML, which commonly causes severe neurological sequelae. We describe the first case of PML in a patient without HIV infection who exhibited remarkable improvement following acute pyelonephritis with Escherichia coli bacteremia.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Improving Translational Accuracy
Improving Translational Accuracy

